Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications

Luigi di Filippo(Vita-Salute San Raffaele University), Andrea Giustina(Vita-Salute San Raffaele University)
Reviews in Endocrine and Metabolic Disorders
April 13, 2021
10.1007/s11154-021-09655-z
Cited by 98

Related Papers

Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
|Endocrine Reviews|2008|894
Acromegaly
|Nature Reviews Disease Primers|2019|387
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
|Endocrine Reviews|2024|280
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response
|Endocrine|2021|46